The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful?
Open accessAbstract
The interindividual variability is an increasingly global problem when treating patients from different backgrounds with diverse customs, metabolism, and necessities. Dose adjustment is frequently based on empirical methods, and therefore, the chance of undesirable side effects to occur is high. Three-dimensional (3D) Printed medicines are revolutionsing the pharmaceutical market as potential tools to achieve personalised treatments adapted to the specific requirements of each patient, taking into account their age, weight, comorbidities, pharmacogenetic, and pharmacokinetic characteristics. Additive manufacturing or 3D printing consists of a wide range of techniques classified in many categories but only three of them are mostly used in the 3D printing of medicines: printing-based inkjet systems, nozzle-based deposition systems, and laser-based writing systems. There are several drawbacks when using each technique and also the type of polymers readily available do not always possess the optimal properties for every drug. The aim of this review is to give an overview about the current techniques employed in 3D printing medicines, highlighting their advantages, disadvantages, along with the polymer and drug requirements for a successful printing. The major application of these techniques will be also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The return of a forgotten polymer—Polycaprolactone in the 21st century
Woodruff, M. A., & Hutmacher, D. W. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.002 · Cited by 4,033
Farah, S., Anderson, D. G., & Langer, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.012 · Cited by 3,443 · cited 7×
“PLA homopolymer has a melting point of 150–175 °C and a Tg of 55 °C [6,31].”
BackgroundMethodInfluentialBiomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Recent advances in 3D printing of biomaterials
Chia, H. N., & Wu, B. M. (2015) · Journal of Biological Engineering · doi:10.1186/s13036-015-0001-4 · Cited by 1,734
Synthesis of polycaprolactone: A review
Labet, M., & Thielemans, W. (2009) · Chemical Society Reviews · doi:10.1039/b820162p · Cited by 1,673
A review of polyvinyl alcohol and its uses in cartilage and orthopedic applications
Baker, M. I., Walsh, S. P., Schwartz, Z., & Boyan, B. D. (2012) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.32694 · Cited by 1,111
Medical Applications for 3D Printing: Current and Projected Uses.
Ventola, C. L. (2014) · PubMed Central · Cited by 920
3D printing in pharmaceutics: A new tool for designing customized drug delivery systems
Goole, J., & Amighi, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.071 · Cited by 660
Stereolithographic (SLA) 3D printing of oral modified-release dosage forms
Wang, J., Goyanes, A., Gaisford, S., & Basit, A. W. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.016 · Cited by 612
Khaled, S. A., Burley, J. C., Alexander, M. R., Yang, J., & Roberts, C. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.028 · Cited by 606
Selective laser sintering (SLS) 3D printing of medicines
Fina, F., Goyanes, A., Gaisford, S., & Basit, A. W. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.082 · Cited by 577
Goyanes, A., Det-Amornrat, U., Wang, J., Basit, A. W., & Gaisford, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.034 · Cited by 490
Recent Advances in Bioink Design for 3D Bioprinting of Tissues and Organs
Ji, S., & Guvendiren, M. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00023 · Cited by 490
Eudragit®: a technology evaluation
Thakral, S., Thakral, N. K., & Majumdar, D. K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.736962 · Cited by 458
3D Printing technologies for drug delivery: a review
Prasad, L. K., & Smyth, H. (2016) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1120743 · Cited by 454
Patient-specific 3D scanned and 3D printed antimicrobial polycaprolactone wound dressings
Muwaffak, Z., Goyanes, A., Clark, V., Basit, A. W., Hilton, S. T., & Gaisford, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.077 · Cited by 314
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
Yi, H.-G., Choi, Y.-J., Kang, K. S., Hong, J. M., Pati, R. G., Park, M. N., Shim, I. K., Lee, C. M., Kim, S. C., & Cho, D.-W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.015 · Cited by 260
Beck, R. C. R., Chaves, P. S., Goyanes, A., Vukosavljevic, B., Buanz, A., Windbergs, M., Basit, A. W., & Gaisford, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.074 · Cited by 249
Goyanes, A., Kobayashi, M., Martínez-Pacheco, R., Gaisford, S., & Basit, A. W. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.021 · Cited by 247
BIODEGRADABLE POLY-EPSILON-CAPROLACTONE (PCL) FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW
Abedalwafa, M. A., Wang, F., Wang, L., & Li, C. (2012) · Cited by 238
Pharmacogenetics and the concept of individualized medicine
Shastry, B. S. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500338 · Cited by 236
Inkjet printing of drug substances and use of porous substrates‐towards individualized dosing
Sandler, N., Määttänen, A., Ihalainen, P., Kronberg, L., Meierjohann, A., Viitala, T., & Peltonen, J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22526 · Cited by 213
Pardeike, J., Strohmeier, D. M., Schrödl, N., Voura, C., Gruber, M., Khinast, J. G., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.033 · Cited by 204
Inkjet printing for pharmaceutical applications
Boehm, R. D., Miller, P. R., Daniels, J., Stafslien, S., & Narayan, R. J. (2014) · Materials Today · doi:10.1016/j.mattod.2014.04.027 · Cited by 182
Vanderburgh, J., Sterling, J. A., & Guelcher, S. A. (2017) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1640-4 · Cited by 182
Perspective: Concepts of printing technologies for oral film formulations
Preis, M., Breitkreutz, J., & Sandler, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.02.032 · Cited by 142
Printing technologies in fabrication of drug delivery systems
Kolakovic, R., Viitala, T., Ihalainen, P., Genina, N., Peltonen, J. P. K., & Sandler, N. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.859134 · Cited by 126
3D-Printed Drugs for Children—Are We Ready Yet?
Preis, M., & Öblom, H. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-016-0704-y · Cited by 120
3D Printing with Biomaterials:
van Wijk, A., & Iris, V. W. (2015) · IOS Press eBooks · doi:10.3233/978-1-61499-486-2-i · Cited by 94
(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.5897/ajpp2013.3906 · Cited by 91
Sin, L. T., Rahmat, A. R., & Rahman, W. A. W. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-2834-3.00002-1 · Cited by 43
Degradation and Stability of Poly(lactic Acid)
Sin, L. T., Rahmat, A. R., & Rahman, W. A. W. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-4459-0.00007-x · Cited by 15
Sin, L. T., Rahmat, A. R., & Rahman, W. A. W. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-4459-0.00001-9 · Cited by 10
Degradation and Stability of Poly(Lactic Acid)
Sin, L. T., & Tueen, B. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814472-5.00007-8 · Cited by 8
Cited by
The Role of 3D Printing in Medical Applications: A State of the Art
Aimar, A., Palermo, A., & Innocenti, B. (2019) · Journal of Healthcare Engineering · doi:10.1155/2019/5340616 · Cited by 685
3D bioprinting of tissues and organs for regenerative medicine
Vijayavenkataraman, S., Yan, W.-C., Lu, W. F., Wang, C.-H., & Fuh, J. Y. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.004 · Cited by 630
Serrano, D. R., Luciano, F. C., Anaya, B. J., Ongoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101328 · Cited by 488
Self-citation3D printing technology; methods, biomedical applications, future opportunities and trends
Bozkurt, Y., & Karayel, E. (2021) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2021.07.050 · Cited by 384
Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020124 · Cited by 356
Metadata
- Authors
- Konta, A., García-Piña, M., & Serrano, D.
- Venue
- Bioengineering
- Publisher
- MDPI AG
- Published
- 2017-09-22
- Volume
- 4
- Issue
- 4
- Pages
- 79
- ISSN
- 2306-5354 (ISSN-L)
- OpenAlex
- W2760581635
- Cited by
- 301
- References
- 34
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.